{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:55:38Z","timestamp":1791705338668,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jcf.2026.05.012","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:48:56Z","timestamp":1780001336000},"page":"844-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors associated with adherence to inhaled medicines in cystic fibrosis following the introduction of elexacaftor\/tezacaftor\/ivacaftor using electronically captured adherence data"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-9921","authenticated-orcid":false,"given":"Robert David","family":"Sandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-0956","authenticated-orcid":false,"given":"Lana Yin Hui","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2903-3215","authenticated-orcid":false,"given":"Sophie","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0752-8898","authenticated-orcid":false,"given":"Tracey Eileen","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin James","family":"Wildman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-9960","authenticated-orcid":false,"given":"Matthew","family":"Sperrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7067-3783","authenticated-orcid":false,"given":"Zhe Hui","family":"Hoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.05.012_bib0001","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcf.2022.05.005","article-title":"Research letter: the impact of elexacaftor\/tezacaftor\/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis","volume":"21","author":"Song","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(24)00118-8","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on utilization of routine therapies in cystic fibrosis: danish nationwide register study","author":"R\u00e5ket","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.012_bib0003","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2024.01.005","article-title":"Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues","volume":"23","author":"Burgel","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.05.012_bib0004","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.chest.2021.06.039","article-title":"Real-world adherence among adults with cystic fibrosis is low: a retrospective analysis of the CFHealthHub digital learning health system","volume":"160","author":"Hoo","year":"2021","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jcf.2026.05.012_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/thoraxjnl-2017-211453","article-title":"Role of habit in treatment adherence among adults with cystic fibrosis","volume":"74","author":"Hoo","year":"2019","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jcf.2026.05.012_bib0006","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.09-3074","article-title":"Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers","volume":"140","author":"Daniels","year":"2011","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jcf.2026.05.012_bib0007","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/14737167.2024.2328085","article-title":"Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy - a multi-center observational study within the CFHealthHub learning health system","volume":"24","author":"Sandler","year":"2024","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jcf.2026.05.012_bib0008","series-title":"Improving inclusion of under-served groups in clinical research: guidance from the nihr-include project uk","year":"2020"},{"key":"10.1016\/j.jcf.2026.05.012_bib0009","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"352","author":"Greenland","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jcf.2026.05.012_bib0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcf.2019.10.008","article-title":"Exploring the implications of different approaches to estimate centre-level adherence using objective adherence data in an adult cystic fibrosis centre - a retrospective observational study","volume":"19","author":"Hoo","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.012_bib0011","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/PPA.S131497","article-title":"An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosis","volume":"Volume 11","author":"Hoo","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jcf.2026.05.012_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.107995","article-title":"Optimising outcomes for adults with cystic fibrosis taking CFTR modulators by individualising care: personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework","volume":"239","author":"Sandler","year":"2025","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.jcf.2026.05.012_bib0013","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","article-title":"Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor","volume":"73","author":"Bessonova","year":"2018","journal-title":"Thorax"},{"issue":"18","key":"10.1016\/j.jcf.2026.05.012_bib0014","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcf.2026.05.012_bib0015","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3390\/jcm10071527","article-title":"Real-world outcomes of ivacaftor treatment in people with cystic fibrosis: a systematic review","volume":"10","author":"Duckers","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.05.012_bib0016","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2021.08.014","article-title":"Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?","volume":"21","author":"Granger","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.05.012_bib0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/17437199.2013.876238","article-title":"A review and analysis of the use of 'habit' in understanding, predicting and influencing health-related behaviour","volume":"9","author":"Gardner","year":"2015","journal-title":"Health Psychol Rev"},{"issue":"1","key":"10.1016\/j.jcf.2026.05.012_bib0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1185\/03007990802619425","article-title":"The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease","volume":"25","author":"McHorney","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.jcf.2026.05.012_bib0019","doi-asserted-by":"crossref","DOI":"10.2196\/17883","article-title":"Habit strength, medication adherence, and Habit-based mobile health interventions across chronic medical conditions: systematic review","volume":"22","author":"Badawy","year":"2020","journal-title":"J Med Internet Res"},{"issue":"1","key":"10.1016\/j.jcf.2026.05.012_bib0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/21642850.2017.1338958","article-title":"Determinants of objective adherence to nebulised medications among adults with cystic fibrosis: an exploratory mixed methods study comparing low and high adherers","volume":"5","author":"Hoo","year":"2017","journal-title":"Health Psychol Behav Med"},{"issue":"5","key":"10.1016\/j.jcf.2026.05.012_bib0021","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/thoraxjnl-2021-217594","article-title":"Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial","volume":"77","author":"Wildman","year":"2022","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.jcf.2026.05.012_bib0022","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1177\/08901171221125326f","article-title":"It's time to unhabit and think critically about whether habit formation has been over valued as a behavior change strategy within health promotion","volume":"36","author":"Segar","year":"2022","journal-title":"Am J Health Promot"},{"issue":"1","key":"10.1016\/j.jcf.2026.05.012_bib0023","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1509\/jppm.25.1.90","article-title":"Interventions to break and create consumer habits","volume":"25","author":"Verplanken","year":"2006","journal-title":"J Public Policy Mark"},{"issue":"1","key":"10.1016\/j.jcf.2026.05.012_bib0024","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1378\/chest.13-1926","article-title":"Pulmonary medication adherence and health-care use in cystic fibrosis","volume":"146","author":"Quittner","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2026.05.012_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(23)00769-5","article-title":"P399 Using a digital learning health system to reduce medicines waste in cystic fibrosis: the easy medicines for burden reduction and care enhancement (EMBRACE) study","volume":"22","author":"Cameron","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.012_bib0026","article-title":"Autism in England: assessing underdiagnosis in a population-based cohort study of prospectively collected primary care data","volume":"29","author":"O'Nions","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jcf.2026.05.012_bib0027","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.jcf.2026.05.012_bib0028","article-title":"Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis","volume":"3","author":"Dawson","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.jcf.2026.05.012_bib0029","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s10096-018-3358-8","article-title":"Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis","volume":"37","author":"Hoo","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326016358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326016358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:07:49Z","timestamp":1790107669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326016358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1569199326016358"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.05.012","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with adherence to inhaled medicines in cystic fibrosis following the introduction of elexacaftor\/tezacaftor\/ivacaftor using electronically captured adherence data","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}